Key Takeaways
- Cindi Newman’s decades‑long avoidance of pap smears stemmed from trauma, misinformation, and personal discomfort.
- The death of her wife, Nikki Marshall, from cervical cancer sparked a critical health wake‑up call.
- HPV testing and cervical cancer screenings have evolved dramatically, now including FDA‑approved at‑home kits.
- Newman’s own self‑screening detected precancerous changes, leading to treatment that spared her life.
- Their story underscores the importance of regular screening and encourages readers to overcome fear and stigma.
A Lifetime of Avoidance
Cynthia “Cindi” Newman, now 63, hadn’t undergone a pap smear in three decades before her wife Nikki Marshall’s death from cervical cancer in 2025. Both women were survivors of childhood sexual abuse, which made the invasive pelvic exam feel “invasive and horrible.” Moreover, they grew up believing the myth that lesbians could not contract HPV or develop cervical cancer. These misconceptions, coupled with a general aversion to medical examinations, kept Newman from routine screening—until Marshall’s diagnosis forced a reckoning.
From Email Pen‑Pals to Life Partners
Newman and Marshall first connected in 2000 through an online exchange that quickly evolved into deep friendship. Their bond grew over shared interests in computing, photography, and football, despite supporting different codes of the sport. After months of correspondence, the pair met in person, with Newman traveling to Scotland to meet Marshall’s family. Their relationship survived visa obstacles, financial strain, and societal prejudice, culminating in a domestic partnership in 2008 and a marriage in 2013 at San Francisco City Hall. Their love story was a testament to resilience and mutual support.
Medical Red Flags and Aggressive Cancer
In 2022, Marshall began experiencing relentless abdominal pain that doctors initially attributed to digestive issues. A CT scan revealed a sizable pelvic mass, prompting a pelvic exam and pap smear that turned excruciatingly painful, leading to a referral to a trauma‑informed specialist at the University of California, San Francisco. A transvaginal ultrasound caused significant bleeding, confirming cervical cancer with a tumor large enough to require immediate chemotherapy, radiation, and a stent to prevent kidney damage. Subsequent surgeries, brachytherapy involving twelve radioactive rods, and ongoing monitoring defined Marshall’s grueling treatment journey—until the disease ultimately proved unstoppable.
From Grief to Self‑Screening Empowerment
After Marshall’s passing, Newman confronted her own fear of medical procedures and began scheduling preventive appointments. She discovered recent advances in cervical cancer screening, including the FDA’s 2025 approval of the Teal Wand, the first at‑home cervical cancer screening kit, and earlier FDA authorizations for self‑collected HPV swabs. These tools allow individuals to collect vaginal samples in private, comparable in discomfort to inserting a tampon. Newman used the Teal Wand, which flagged high‑risk HPV, leading to a follow‑up at UCSF where severe precancerous dysplasia was identified and promptly treated.
Advocacy and the New Screening Landscape
Now cancer‑free, Newman has turned her personal tragedy into a public health crusade. She urges anyone—especially women and people with a cervix—to prioritize early, frequent screening, stressing that modern options remove many barriers that once discouraged routine exams. The American Cancer Society now recognizes self‑collected specimens as valid for cervical cancer screening, reflecting a shift toward patient‑centered care. Newman’s advocacy aligns with updated clinical guidelines recommending primary HPV testing every five years for average‑risk individuals aged 25–65, while emphasizing the necessity of personalized discussions with healthcare providers.
Legacy of Love and Prevention
Newman’s journey illustrates how personal loss can catalyze societal change. By sharing Marshall’s story and her own experience with at‑home HPV testing, she hopes to dismantle stigma, dispel myths about LGBTQ+ health risks, and empower others to seek screening without shame. “Please get screened for yourself, your peace of mind, and for those who love you,” she implores. Her message is clear: advances in screening technology have erased many excuses for delay, and proactive health measures can truly save lives—just as Marshall’s memory continues to inspire action and hope.